![Martin Lehr](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Martin Lehr
Founder at
CONTEXT THERAPEUTICS INC.
Net worth: 3 M $ as of 31/05/2026
Profile
Martin A. Lehr is the founder of Context Therapeutics LLC, founded in 2016, serving as Chief Executive Officer & Director.
Mr. Lehr is the founder of Context Therapeutics, Inc., founded in 2015, serving as President, Chief Executive Officer & Director.
Current jobs include Director at The Biobreak Organization, Inc. since 2009, Independent Director at Praesidia Biotherapeutics, Inc. since 2020, and Board Member at CureDuchenne Ventures LLC since 2019.
Former job includes Senior Associate at OUP Management Co. LLC.
Education includes a graduate degree from The Trustees of Columbia University in The City of New York in 2009 and an undergraduate degree from the University of Pennsylvania in 2006.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 13/04/2026 | 1,079,891 ( 1.18% ) | 3 M $ | 31/05/2026 |
Martin Lehr active positions
| Companies | Position | Start |
|---|---|---|
| CONTEXT THERAPEUTICS INC. | Founder | 01/04/2015 |
Context Therapeutics LLC
 Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures hormone-responsive cancer drugs | Founder | 01/01/2016 |
The Biobreak Organization, Inc. | Director/Board Member | 01/01/2009 |
Praesidia Biotherapeutics, Inc.
 Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Provides therapy to overcome drug addiction | Director/Board Member | 01/11/2020 |
CureDuchenne Ventures LLC
 CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements. | Director/Board Member | 01/05/2019 |
Former positions of Martin Lehr
| Companies | Position | End |
|---|---|---|
OUP Management Co. LLC
 OUP Management Co. LLC Investment ManagersFinance Osage Partners invests in companies located across the globe primarily in the United States. The firm targets companies operating in the fields of technology and life science sectors includes software, hardware, climate tech, therapeutics, medtech, diagnostics, research tools enabled services companies. It provide financing for pre-seed to late stage capital requirements with investment size ranges from USD1 million to USD20 million. It acts as a lead or co-lead investor. | Private Equity Analyst | - |
Training of Martin Lehr
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
96
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
 University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
OUP Management Co. LLC
OUP Management Co. LLC Investment ManagersFinance Osage Partners invests in companies located across the globe primarily in the United States. The firm targets companies operating in the fields of technology and life science sectors includes software, hardware, climate tech, therapeutics, medtech, diagnostics, research tools enabled services companies. It provide financing for pre-seed to late stage capital requirements with investment size ranges from USD1 million to USD20 million. It acts as a lead or co-lead investor. | Finance |
CureDuchenne Ventures LLC
CureDuchenne Ventures LLC Investment ManagersFinance CureDuchenne Ventures seeks investment opportunities located in the United States. The firm targets companies operating in the fields of health technology companies. It provides financing for early-stage capital requirements. | Finance |
Context Therapeutics LLC
Context Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures hormone-responsive cancer drugs | Health Technology |
Context Therapeutics, Inc.
 Context Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops treatment options for women living with hormone-dependent cancer | Health Technology |
The Biobreak Organization, Inc. | |
Praesidia Biotherapeutics, Inc.
Praesidia Biotherapeutics, Inc. Medical/Nursing ServicesHealth Services Provides therapy to overcome drug addiction | Health Services |
- Stock Market
- Insiders
- Martin Lehr
